Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical ... could make it more effective at disrupting bacterial cell membranes, proteins, and DNA, potentially leading ...

Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical ... a preclinical study of Telomir-1 on human retinal cell lines. Data from the test showed the ability of Telomir ...

Telo has raised some US$6.8 million over the last couple of years with its vision to build a compact, performance electric truck with a full-size bed and the footprint of a Mini Cooper SE. The ...